drugset / Trial / NCT01906840

Role of Turmeric on Oxidative Modulation in ESRD Patients

NCT01906840

Phase 1/2 Completed 48 enrolled Shiraz University of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Despite advances in prevention of cardiovascular diseases, the incidence of accelerated atherosclerosis in hemodialysis (HD) patients has still remained high. Oxidative stress is considered as a major player in uremia associated morbidity and mortality in HD patients. The aim of this study was to evaluate the effects of turmeric on oxidative stress markers in HD patients.

Timeline

Start
2011-04
Primary completion
2012-08
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Turmeric Traditional medicine (herbal / TCM) 500 mg